Your trusted CRO partner
At Aquila, we offer preclinical contract research based on world-leading expertise in immunology, immuno-oncology and specialist histology.
We are proud to be the first CRO to be built from a solid immunology base. Founded at the University of Edinburgh, we were among the first CROs to specialise in immuno-oncology research services and our Chief Scientific Officer still holds a professorship.
A key feature of our services is we partner with leading academics to provide you with expert advice and interpretation of your data. We work closely with you to develop a custom package of work to support your drug discovery pipeline, including off-the-shelf and novel assays.
We work across multiple therapeutic areas, developing and delivering highly specialist solutions, and bringing innovative academic models e.g. MLRs, exhausted T cell assays and RNAscope, to the heart of drug development.
Together with our expert selection of protocols, we can reduce the cost of your project, helping you define your leads faster, and ensuring your best route to clinic.